Expert Review of Clinical Pharmacology [ISSN 1751-2433]; [e-ISSN 1751-2441] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on all aspects of clinical safety, tolerability, efficacy and therapeutic applications.
The journal also covers toxicity issues, adverse reactions, pharmacoeconomics, and societal issues. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore, the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.
Please note that the journal does not publish preclinical or Phase I-II studies, unless there is a clear indication for translational medicine. Each article is structured to incorporate the author's own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.
Expert Review of Clinical Pharmacology aims to address the needs of clinical and pharmaceutical researchers, drug development specialists, physicians, and other specialists and players who are actively meeting such challenges in modern biomedical practice.
The Editors welcome novel research in the following key areas:
- ADME studies and PK/PD modelling
- Novel clinical trial design and conduct
- Toxicity and carcinogenesis
- Adverse effects/reactions, drug–drug and drug–disease interactions
- Pharmacogenetics, genomics and the incorporation of new biomarkers in drug development and clinical practice
- Pharmacoepidemiology, risk management and pharmacovigilance
- Pharmacotherapy in specific groups of people, such as children, women, the immunocompromised, and different ethnicities
- Impact on quality of life and pharmacoeconomic issues
- Regulation of drug development and marketing
- Epidemiology and biostatistics
The journal welcomes:
- Reviews
- Original research
- Editorials
- Drug profiles
- Meta-analyses
- Letters to the Editor
Please note that the journal does not publish case reports or case series. Letters to the Editor should discuss articles previously published in the journal.
Comprehensive coverage in each review article is complemented by the unique Expert Collection format and includes the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results.
Article Highlights – an executive summary of the author’s most critical points.
Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.
Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Review of Clinical Pharmacology, part of the Expert Collection brand.
Authors can choose to publish gold open access in this journal and may choose to publish using our Accelerated Publication services.
For any pre-submission enquiries, please contact the Commissioning Editor.
Editor-in-Chief
Prof. Peter Penson, Liverpool John Moores University, Liverpool, UK
Associate Editors
Prof. Arshad Jahangir, Mayo Clinic, Rochester, MN, USA
Dr. Qing Ma, SUNY Buffalo, Buffalo, NY, USA
Prof. Maarten Postma, Groningen University, Groningen, The Netherlands
Prof. Julia C Stingl, University of Ulm, Ulm, Germany
Prof. John Van Den Anker, Children's National Hospital, Washington, DC, USA
Prof. Xiangdong Wang, Fudan University, Shanghai, China
Editorial Advisory Panel
Dr. Christopher P Alderman, University of South Australia, Adelaide, Australia
Prof. Robert Barkin, Rush University, Chicago, IL, USA
Dr. Edward Bednarczyk, SUNY Buffalo, Buffalo. NY, USA
Prof. Bernard MY Cheung, University of Hong Kong, Hong Kong, China
Dr. Ron Herings, PHARMO Institute, Utrecht, The Netherlands
Prof. Paula Hoffman, University of Colorado, Boulder, CO, USA
Dr. Shiew-Mei Huang, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, USA
Dr. Amalia Issa, University of Houston, Houston, TX USA
Dr. Vikas Khurana, Insys Therapeutics Inc., Phoenix, AZ, USA
Prof. Mohammad Amjad Kamal, King Abdulaziz University, Jeddah, Saudi Arabia
Dr. Hari V Kalluri, AbbVie Inc, North Chicago, IL, USA
Dr. Vasundhra Kashyap, Shire Pharmaceuticals, Lexington, MA, USA
Dr. Hedva B Levy, HbL PharmaConsulting, St. Louis, MO, USA
Prof. Arduino A Mangoni, Flinders Medical Centre, South Australia, Australia
Dr. Alice McCloskey, Liverpool John Moores University, Liverpool, UK
Dr. Dirk Mentzer, Paul Ehrlich Institute, Langen, Germany
Prof. Mikko Niemi, Helsinki Univ. Central Hospital, Helsinki, Finland
Dr. Ewa Olech, University of Nevada School of Medicine, Reno, NV, USA
Prof. Philip Patsalos, Institute of Neurology, University College London, London, UK
Prof. Kannan Sridharan, Arabian Gulf University, Manama, Bahrain
Dr. Janet Sultana, University of Exeter, Exeter, UK
Dr. Omar Viswanath, Creighton University School of Medicine, Omaha, NE, USA and University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA
Dr. Scott A Waldman, Thomas Jefferson University, Philadelphia, PA, USA
Dr. Stephen Waring, York Hospital, York, UK
Expert Review of Clinical Pharmacology is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})
![Gates Open Research is a platform for rapid author-led publication and open peer review of research funded by the Bill & Melinda Gates Foundation.]({"type":"image" , "src" : "/sda/112431/GATES-KB.jpg"})